✦ LIBER ✦

Randomized phase I study of weekly or every other week gemcitabine (GEM) plus cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by van Zandwijk, N; Schoemaker, N; Baas, P; Pluim, D; Malliepaard, M; Sparidans, R.W; Schot, M; Beijnen, J.H; Schellens, J.H.M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of gemcitabine (GEM) and c

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Gemcitabine (GEM) — Cisplatin (COOP) — V

✍ Comella, P.; Panza, N.; Frasci, G.; Pacilio, C.; Nicolella, G.P.; Natale, M.; De 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

231 Gemcitabine (GEM)-cisplatin (CDDP)-v

✍ Comella, P.; Panza, N.; Frasci, G.; Pacilio, C.; Nicolella, G.P.; Natale, M.; De 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Randomized, multicenter, phase II study

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Phase I/II trial of gemcitabine plus doc

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

32 Single-agent Gemzar® (Gemcitabine, GE

✍ Manegold, Ch.; Stahel, R.; Mattson, K.; Ricci, S.; van Walree, N.C.; Bergman, B. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 131 KB